Monte Carlo calculation of radioimmunotherapy with ^90Y-, ^177Lu-, ^131I-, ^124I-, and ^188Re-nanoobjects: choice of the best radionuclide for solid tumour treatment by using TCP and NTCP concepts
DOI10.1155/2015/284360zbMATH Open1344.92073DBLPjournals/cmmm/LucasFGMMB15OpenAlexW2032708900WikidataQ42093083 ScholiaQ42093083MaRDI QIDQ308774FDOQ308774
Authors: S. Lucas, O. Feron, B. Gallez, B. Masereel, C. Michiels, T. Vander Borght 
Publication date: 6 September 2016
Published in: Computational \& Mathematical Methods in Medicine (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1155/2015/284360
Recommendations
- Are more complicated tumour control probability models better?
- Immune system - tumour efficiency ratio as a new oncological index for radiotherapy treatment optimization
- Monte Carlo techniques in radiation therapy
- Multinomial model-based formulations of TCP and NTCP for radiotherapy treatment planning
- Linear quadratic and tumour control probability modelling in external beam radiotherapy
This page was built for publication: Monte Carlo calculation of radioimmunotherapy with \(^{90}\)Y-, \(^{177}\)Lu-, \(^{131}\)I-, \(^{124}\)I-, and \(^{188}\)Re-nanoobjects: choice of the best radionuclide for solid tumour treatment by using TCP and NTCP concepts
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q308774)
